DGAP-News: MPH Mittelständische Pharma Holding AG / Key word(s):
9-month figures/Quarter Results
MPH Mittelständische Pharma Holding AG: + 45 % profit growth in the
first 9 months 2014
25.11.2014 / 12:00
---------------------------------------------------------------------
In the first 9 months 2014 MPH Group achieved sales of EUR 163.80 million
(Prior-year period: EUR 169.78 million). Net profit increased by 45 % to
EUR 8.98 million (Prior-year period: EUR 6.18 million).
The business strategy of "making a contribution towards maintaining
healthcare affordable" has paid off. In the healthcare market MPH AG is
following this strategy with an attractive offer of drugs (HAEMATO AG) and
medical services (M1 Med Beauty AG).
"The healthcare segment contributes an ever increasing share to the Group's
profit. This confirms the success of our strategy. We are confident that
the contribution of M1 Med Beauty AG to the success of the Group will rise
continuously by the further expansion. For the year 2015 the autonomous
listing of the company in the Entry Standard of the Frankfurt stock
exchange is considered", says Dr. Christian Pahl, Member of the Management
Board of MPH AG.
About MPH Mittelständische Pharma Holding AG:
The company MPH Mittelständische Pharma Holding AG, based in Berlin, has
strategically concentrated its activities on the growth segments Pharma and
Healthcare. The pharmaceutical sector makes a contribution towards cutting
costs in the healthcare system with medicines manufactured on the basis of
patent-free and patent-protected active substances for the therapy of
chronic diseases. The field of healthcare offers a variety of services for
individual patient therapies, aesthetic surgeries and other medical
treatments.
MPH Mittelständische Pharma Holding AG is listed in the Entry Standard
(Open Market) of the Frankfurt stock exchange.
Key figures for the share of MPH Mittelständische Pharma Holding AG:
Subscribed capital: EUR 42,813,842
Listed shares: ordinary shares
ISIN: DE000A0L1H32
WKN: A0L1H3
Stock symbol: 93M
Contact: Linda Reichelt
MPH Mittelständische Pharma Holding AG
FasanenstraÃe 77
D-10623 Berlin
Phone:+49 (0) 30 897308660 Fax:+49 (0) 30 897308669
E-Mail: ir@mph-ag.de Web: www.mph-ag.de
---------------------------------------------------------------------
25.11.2014 Dissemination of a Corporate News, transmitted by DGAP - a
service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------
Language: English
Company: MPH Mittelständische Pharma Holding AG
FasanenstraÃe 77
10623 Berlin
Germany
Phone: 030 / 897 308 660
Fax: 030 / 897 308 669
E-mail: info@mph-ag.de
Internet: www.mph-ag.de
ISIN: DE000A0L1H32
WKN: A0L1H3
Listed: Freiverkehr in Berlin, Düsseldorf, Stuttgart; Frankfurt in
Open Market (Entry Standard)
End of News DGAP News-Service
---------------------------------------------------------------------
299221 25.11.2014
DGAP-News: MPH Mittelständische Pharma Holding AG: + 45 % profit growth in the first 9 months 2014
| Source: EQS Group AG